Regencell Bioscience Holdings Limited Ordinary Shares (RGC)

About RGC

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong K…

Sector

Health Care

Industry

Medicinal Chemicals and Botanical Products

Employees

10

Website

www.regencellbioscience.com/

Fundamentals

1-day range

$5.42$6.1

Market cap

$2.70B

P/E (trailing)

—

P/E (forward)

—

EPS (trailing)

$-0.01

Dividend yield

—

Beta

1.27

Avg. volume

305.9K

Regencell Bioscience Holdings Limited Ordinary Shares Competitors

Chosen by industry and closest market cap.

• RGC

  Regencell Bioscience Holdings Limited Ordinary Shares

  $5.52

  ▼ 0.09%
  Market cap $2.70BP/E —
  $4.51$69
• RLX

  RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share

  $1.83

  ▲ 1.67%
  Market cap $3.08BP/E 16.68
  $1.76$2.84
• GLAS

  Glass House Brands Inc. Subordinate Voting Shares

  $9.92

  ▲ 1.43%
  Market cap $760.64MP/E —
  $5.03$14
• TLRY

  Tilray Brands Inc. Common Stock

  $4.58

  ▲ 0.22%
  Market cap $517.36MP/E —
  $3.67$23.2
• CGC

  Canopy Growth Corporation Common Shares

  $1.01

  ▲ 0.00%
  Market cap $400.49MP/E —
  $1.18$3.28
• DFTX

  Definium Therapeutics Inc. Common Shares

  $41

  ▼ 6.44%
  Market cap $5.03BP/E —
  $8.7$49.7
• SNDL

  SNDL Inc. Common Shares

  $1.36

  ▲ 0.74%
  Market cap $312.36MP/E —
  $1.17$2.89

P/E shows — for peers not currently carrying a live signal of their own.

• HUI EVANA YEE WAH · May 27, 2026 · Disposition

  19.0K
• LO WILLIAM WING YAN DR · May 27, 2026 · Disposition

  70.6K